Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism AKR1B1 inhibitors(Aldose reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | Pakistan | 24 Apr 2025 |